Increase in Stress Cardiomyopathy Incidence During the COVID-19 Pandemic
The incidence of stress cardiomyopathy has increased during the COVID-19 pandemic.
The incidence of stress cardiomyopathy has increased during the COVID-19 pandemic.
This is the first study to describe the safety of IL-6 blockade with intravenous sarilumab in patients with COVID-19 pneumonia with systemic hyperinflammation.
Researchers evaluated the risk for COVID-19 infection and its severity in patients receiving DMARDs.
Greater physical activity may be associated with reduced risk for heart failure in several high-risk subgroups.
Careful consideration should be taken before using hydroxychloroquine in patients with diabetes, particularly in the context of COVID-19.
Researchers found that risk factors differ between various first manifestations of cardiovascular disease in patients with type 1 diabetes.
Plasma levels of high-sensitivity cardiac troponins can improve the stratification of mortality risk beyond the comorbidity burden in older adults with diabetes.
Individuals with diabetes are at increased risk for acute mesenteric ischemia, an emergency vascular complication.
Clinical guidelines from the American Thyroid Association are inconsistent with the GRADE framework in assigning strength of recommendations.
Prenatal exposure to n-butyl paraben was associated with early overweight development in girls in an epidemiologic and translational study.